An experimental study of consecutive administration of ropinirole and apomorphine for emesis induction in dogs
Journal of Veterinary Emergency and Critical Care · 2024-01 · 34 (1) · 31-39
DOI: 10.1111/vec.13339 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Emergency and Critical Care, online erschienen am 09.11.2023. Verfasst von Lasse I Saloranta und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research and Development, Orion Pharma, Orion Corporation, Espoo, Finland. Hauptthemen laut MEDLINE: Apomorphine, Vomiting, Indoles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
To study the safety and effectiveness of consecutively administered ropinirole and apomorphine (both dopamine 2‐like receptor agonists) for emesis induction in dogs.
Design
Prospective, crossover study design.
Setting
Institutional animal research facility. Animals Six healthy male purpose‐bred Beagle dogs.
Interventions
Each dog received 4 treatments: (1) apomorphine infusion (21 μg/kg) over 30 minutes + ropinirole eye drops (3.75 mg/m 2 ); (2) ropinirole infusion (108 μg/m 2 ) over 30 minutes + apomorphine SC (100 μg/kg); (3) apomorphine SC (100 μg/kg) + ropinirole eye drops (7.5 mg/m 2 ) after 30 minutes; and (4) ropinirole eye drops (7.5 mg/m 2 ) + apomorphine SC (100 μg/kg) after 30 minutes. Infusions were administered via a catheter instrumented in the cephalic vein. Eye drops and SC injections were administered as described in the product inserts. Blood samples were taken for ropinirole and apomorphine concentration analysis before dosing and periodically following administrations. The washout period between the treatments was 5–7 days. Measurements and Main Results Number of vomits and clinical signs were recorded. Alertness and heart rate were monitored in conjunction with blood sampling. The average number of vomits varied between 4.3 and 8.8 (range 1–16) following treatments. Signs of nausea, vomiting, and lethargy were seen in all individuals without significant differences between treatments. Moderate to marked, transient increase in heart rates was detected in all treatments. Infrequent noted side effects included ocular hyperemia, blepharospasms, and muscle tremors. Prior treatment with apomorphine significantly decreased the absorption of ropinirole eye drops.
Conclusions
The safety and efficacy profiles of this experimental study support that ropinirole and apomorphine could be administered consecutively in cases where the treatment using 1 substance has resulted in an incomplete evacuation of the stomach contents, and the attending veterinarian considers the use of a different agent to have benefits that outweigh the risks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Research and Development, Orion Pharma, Orion Corporation, Espoo, Finland.
ORCID-Profile: Lasse I Saloranta
Zitieren
APA
Saloranta, L. I., Levijoki, J. M., & Vuorela, A. M. (2024). An experimental study of consecutive administration of ropinirole and apomorphine for emesis induction in dogs. Journal of Veterinary Emergency and Critical Care, 34(1), 31-39. https://doi.org/10.1111/vec.13339
Vancouver
Saloranta LI, Levijoki JM, Vuorela AM. An experimental study of consecutive administration of ropinirole and apomorphine for emesis induction in dogs. Journal of Veterinary Emergency and Critical Care. 2024;34(1):31-39. doi:10.1111/vec.13339
BibTeX
@article{Saloranta2024,
author = {Saloranta, Lasse I and Levijoki, Jouko M and Vuorela, Arja M},
title = {An experimental study of consecutive administration of ropinirole and apomorphine for emesis induction in dogs},
journal = {Journal of Veterinary Emergency and Critical Care},
year = {2024},
volume = {34},
number = {1},
pages = {31--39},
doi = {10.1111/vec.13339}
}
EUVIMED